The Full Climb: S$82,823 → S$150,000
Phase 1 — S$82,823 → S$100,000 (Target: 2026 H2–2027)
1) IBKR Cash Redeployment
USD118,657 idle cash (live IBKR pull, 1 Sep 2026, up from USD112,942 in the prior version of this page) deployed at ~5%, matching existing bond coupons. No new risk category introduced.
2) Schwab Reallocation
USD74,895 shifted toward dividend-focused holdings at ~4% yield.
3) New Capital / CPF ERS
Either ~S$124,000 fresh capital at 5%, or CPF ERS top-up (guaranteed, but locked until Jun 2029).
Phase 2 — S$100,000 → S$150,000 (Target: 2027–2032)
A) Bond Reinvestment on Roll
As Keppel REIT, StanChart, ESR-REIT and others reach call dates, reinvest at a modestly higher average coupon (~5.5% vs current ~4.6%) rather than accepting whatever the next coupon reset offers. Risk: reinvestment risk only — capital is not at risk beyond what it already was as a bondholder.
B) Modest Additional Leverage
Your current CIMB-linked financing sits at a conservative 25.6% loan-to-value against S$3.03M gross assets. Extending to a still-conservative 45% LTV (well below typical 50–60% ceilings) frees ~S$590,000 in financing capacity at an estimated 2% net spread (borrow ~3%, deploy ~5%). Risk: leverage amplifies both gains and losses; only pursue if rates stay favourable.
C) Dividend Equity Sleeve
Shifting ~40% of the IBKR equity position (live value now USD261,216 as of 1 Sep 2026, up from USD255,001) from growth-oriented holdings into dividend/REIT names yielding ~6% adds meaningful income with no new capital required. Risk: equity market risk, dividend cuts possible in downturns.
Note: the +S$5,853/yr figure was not recalculated this pass — it appears to net out an existing dividend yield already earned on the growth holdings, an assumption not fully documented on this page. Confirm methodology before treating an updated figure as reliable.
D) Diversified Private Credit
Deploying ~S$200,000 of new or freed-up capital into diversified structured credit or private debt (similar risk category to your existing Astrea 9 holdings) at ~7% yield. Risk: highest in this set — credit risk, illiquidity, and structural complexity. Diversify across multiple issuers; do not concentrate.
Timeline — Year by Year
| Period | Action | Income Added | Running Total | Risk Level |
|---|---|---|---|---|
| 2026 H2 | Redeploy IBKR USD cash + Schwab reallocation | +S$11,000 | S$93,823 | Low |
| 2027 | CPF/new capital decision resolved | +S$6,177 | S$100,000 | Low–Med |
| 2027–2028 | IBKR equity sleeve shifted to dividend/REIT yield | +S$5,853 | S$105,853 | Medium |
| 2028–2029 | Deploy into diversified private credit / structured notes | +S$14,000 | S$119,853 | Med–High |
| 2029 | Evaluate additional financing as first bond calls arrive (Keppel REIT) | monitor | S$119,853 | Review |
| 2029–2032 | Bond reinvestment at higher coupon on calls; phased leverage increase | +S$25,497 | S$145,350 | Medium |
Income Build by Lever
Risk Profile by Phase
What This Plan Deliberately Avoids
| Avoided | Why |
|---|---|
| Touching 401(k) / CPF principal | Retirement capital stays ring-fenced; only CPF ERS top-up (Phase 1, optional) is considered, and only as new contribution, never a withdrawal |
| Borrowing against the home | Additional leverage in Lever B uses existing insurance-linked facilities only, not property-secured debt |
| Concentrating in a single high-yield issuer | Lever D is explicitly diversified across multiple structured credit issuers, not a single concentrated bet |
| Chasing yield above ~7% | Yields meaningfully above 7% in current rate environment typically signal credit risk beyond what this plan accepts |
| Selling insurance policies for cash value | NTUC and Singlife cash values remain untouched — they continue compounding as designed |